- |||||||||| Trial completion, Enrollment change, Trial primary completion date: Pelvic Examination in Pregnancy (clinicaltrials.gov) - Feb 18, 2016
P=N/A, N=270, Completed, Active, not recruiting --> Completed | N=106 --> 54 | Trial primary completion date: Dec 2016 --> Dec 2015 Recruiting --> Completed | N=800 --> 270 | Trial primary completion date: Jan 2013 --> Jan 2016
- |||||||||| Trial completion, Trial primary completion date: Body Image Therapy in Anorexia Nervosa (clinicaltrials.gov) - Feb 13, 2016
P=N/A, N=100, Completed, Recruiting --> Completed | N=800 --> 270 | Trial primary completion date: Jan 2013 --> Jan 2016 Recruiting --> Completed | Trial primary completion date: Oct 2015 --> Feb 2016
- |||||||||| Linzess (linaclotide) / Astellas, Ironwood Pharma, AbbVie
Trial completion, Trial primary completion date: Trial of Linaclotide in Patients With Chronic Idiopathic Constipation (clinicaltrials.gov) - Feb 12, 2016 P3, N=1223, Completed, Recruiting --> Completed | Trial primary completion date: Oct 2015 --> Feb 2016 Recruiting --> Completed | Trial primary completion date: Jul 2016 --> Aug 2015
- |||||||||| omeprazole / Generic mfg.
Trial suspension: Use of Maytenus Ilicifolia in the Treatment of Dyspepsia (clinicaltrials.gov) - Jan 28, 2016 P2, N=140, Suspended, N=16 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Jan 2014 --> Oct 2015 Recruiting --> Suspended
- |||||||||| Trial primary completion date, Surgery, Metastases: Decreasing Narcotics in Advanced Pelvic Surgery (clinicaltrials.gov) - Jan 26, 2016
P4, N=136, Recruiting, N=20 --> 0 | Terminated --> Withdrawn Trial primary completion date: Jan 2016 --> May 2016
- |||||||||| Enrollment change, Trial termination, Trial primary completion date: Dose-Responsive Effect of Polydextrose on Whole Gut Transit Time (clinicaltrials.gov) - Jan 22, 2016
P=N/A, N=59, Terminated, Active, not recruiting --> Terminated; low incidence N=184 --> 59 | Active, not recruiting --> Terminated | Trial primary completion date: Jan 2015 --> Nov 2013; Slow recruitment
- |||||||||| Emend intravenous (fosaprepitant) / Merck (MSD), Ono Pharma
Trial termination, Metastases: Fosaprepitant for N/V With High-dose Interleukin-2 for Metastatic Melanoma and Renal Cell Carcinoma (clinicaltrials.gov) - Jan 21, 2016 P2b, N=12, Terminated, N=184 --> 59 | Active, not recruiting --> Terminated | Trial primary completion date: Jan 2015 --> Nov 2013; Slow recruitment N=22 --> 12 | Recruiting --> Terminated | Trial primary completion date: Sep 2015 --> Sep 2016 | Recruiting --> Terminated; Enrollment issues
- |||||||||| dexamethasone injection / Generic mfg.
Trial primary completion date: Dexamethasone for Post-cesarean Delivery Pain (clinicaltrials.gov) - Jan 21, 2016 P4, N=104, Recruiting, N=22 --> 12 | Recruiting --> Terminated | Trial primary completion date: Sep 2015 --> Sep 2016 | Recruiting --> Terminated; Enrollment issues Trial primary completion date: Dec 2015 --> Dec 2016
- |||||||||| Acofide (acotiamide) / Zeria, Astellas
Enrollment closed, P3 data, Enrollment change, Trial primary completion date: Phase III, Long-term, Open-label Safety Study of Z-338 (clinicaltrials.gov) - Jan 19, 2016 P3, N=207, Active, not recruiting, Recruiting --> Active, not recruiting | N=70 --> 21 Recruiting --> Active, not recruiting | N=350 --> 207 | Trial primary completion date: Jan 2016 --> Feb 2017
- |||||||||| Trial primary completion date: Neural Links Between OCD and Anorexia (clinicaltrials.gov) - Jan 18, 2016
P=N/A, N=45, Recruiting, Recruiting --> Active, not recruiting | N=350 --> 207 | Trial primary completion date: Jan 2016 --> Feb 2017 Trial primary completion date: Jan 2016 --> Aug 2016
- |||||||||| fluoxetine / Generic mfg.
Trial completion, Enrollment change: PET Imaging Study of Recovered Anorexics (clinicaltrials.gov) - Jan 16, 2016 P=N/A, N=23, Completed, N=20 --> 0 Active, not recruiting --> Completed | N=120 --> 23
- |||||||||| Trial initiation date, Trial primary completion date: Recurrent Abdominal Pain in Children (clinicaltrials.gov) - Jan 7, 2016
P2, N=168, Completed, Recruiting --> Completed | N=240 --> 165 | Trial primary completion date: Jun 2014 --> Jul 2015 Initiation date: Jul 2007 --> Jan 2009 | Trial primary completion date: Dec 2013 --> Mar 2014
- |||||||||| Barhemsys (intravenous amisulpride) / Acacia Pharma
Trial completion: Phase IIIb Study of APD421 in Combination as PONV Prophylaxis (clinicaltrials.gov) - Jan 5, 2016 P3, N=1204, Completed, Initiation date: Jul 2007 --> Jan 2009 | Trial primary completion date: Dec 2013 --> Mar 2014 Recruiting --> Completed
- |||||||||| Trial primary completion date: Lcr35 for Children With Functional Constipation (clinicaltrials.gov) - Dec 30, 2015
P4, N=94, Recruiting, Recruiting --> Active, not recruiting Trial primary completion date: Dec 2015 --> Jun 2016
- |||||||||| Carafate (sucralfate) / AbbVie
Enrollment change, Trial withdrawal, Trial primary completion date: CE_NERD: Confocal Endomicroscopy for Non-Erosive Reflux Disease (CE NERD) (clinicaltrials.gov) - Dec 10, 2015 P=N/A, N=0, Withdrawn, Active, not recruiting --> Completed N=120 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Jan 2015 --> Dec 2015
- |||||||||| Enrollment closed: TreCogAM: Cognitive Remediation Therapy in Anorexia Nervosa (clinicaltrials.gov) - Dec 10, 2015
P=N/A, N=120, Active, not recruiting, N=120 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Jan 2015 --> Dec 2015 Recruiting --> Active, not recruiting
- |||||||||| Trial completion, Enrollment change, Trial primary completion date: Internet Intervention for Adolescents With Chronic Pain (clinicaltrials.gov) - Dec 5, 2015
P2, N=273, Completed, Trial primary completion date: Oct 2015 --> Oct 2016 Active, not recruiting --> Completed | N=600 --> 273 | Trial primary completion date: Aug 2015 --> Nov 2015
- |||||||||| Xifaxan (rifaximin) / Alfa Wassermann, Bausch Health, Norgine, ASKA Pharma
Trial completion, Trial primary completion date: Rifaximin for Functional Dyspepsia (clinicaltrials.gov) - Dec 5, 2015 P2/3, N=95, Completed, Active, not recruiting --> Completed | N=600 --> 273 | Trial primary completion date: Aug 2015 --> Nov 2015 Recruiting --> Completed | Trial primary completion date: Sep 2015 --> May 2015
- |||||||||| Trial completion, Trial primary completion date: Virtual Reality Based Cue-exposure Treatment for Bulimia Nervosa (clinicaltrials.gov) - Dec 4, 2015
P=N/A, N=60, Completed, Trial primary completion date: Apr 2016 --> Apr 2017 Not yet recruiting --> Completed | Trial primary completion date: Jul 2015 --> Oct 2015
- |||||||||| Cesamet (nabilone) / Bausch Health, Viatris
Trial completion, Trial primary completion date, Surgery: Study of Prevention of Postoperative Nausea and Vomiting Using Cesamet (clinicaltrials.gov) - Dec 4, 2015 P2, N=331, Completed, Not yet recruiting --> Completed | Trial primary completion date: Jul 2015 --> Oct 2015 Recruiting --> Completed | Trial primary completion date: Apr 2016 --> Jan 2015
|